MIRA Pharmaceuticals, Inc. Common Stock

MIRANASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
0.68 USD
↗ 0.06 (9.95%)AT CLOSE (11:59 AM EDT)
0.69
↗ 0.01 (1.63%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
0.69
↗ 0.01 (1.63%)
🔴Market: CLOSED

MIRA is currently priced at $0.68. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, MIRA trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 4, 2026.

Open?$0.65
High?$0.73
Low?$0.65
Prev. Close?$0.61
Volume?352.3K
Avg. Volume?86.8K
VWAP?$0.69
Rel. Volume?4.06x
Bid / Ask
Bid?$0.67 × 1.4K
Ask?$0.72 × 400
Spread?$0.05
Midpoint?$0.70
Valuation & Ratios
Market Cap?28.6M
Shares Out?42.0M
Float?29.2M
Float %?69.5%
P/E Ratio?N/A
P/B Ratio?3.06
EPS?-$0.75
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
Themes
Biotech - Drug Development›Neuroscience & CNSCannabis›CBD & Hemp Products
Employees
2
Market Cap
25.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.mirapharmaceuticals.com
Listed
2023-08-03
Address
1200 BRICKELL AVENUE
MIAMI, FL 33131
Phone: 813-369-5150
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
68
Piotroski F-Score?0/9Weak
Altman Z-Score?125.76Safe
Confidence?40%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?0.87%Low
Short Interest?255.3K
Days to Cover?5.5
Free Float29.2M
Avg Daily Volume46.3K
Settlement Date2026-07-15
Financial Health
Current Ratio?82.16Strong
Quick Ratio?82.16Strong
Cash Ratio?41.96Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
55
3.06FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-335.5%WEAK▾
ROA?
S&P
3
-331.4%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$23.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist